Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion type Assertion NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_head.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion evidence source_evidence_literature NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion SIO_000772 23033490 NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion wasDerivedFrom befree-20150227 NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion wasGeneratedBy ECO_0000203 NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.